Cold Application on the Subcutaneous Injection
Injection Site Bruising, Bruising, Pain
About this trial
This is an interventional supportive care trial for Injection Site Bruising focused on measuring bruising, cold application, haematoma, low molecular weight heparin, nursing, pain, subcutaneous injection
Eligibility Criteria
Inclusion Criteria: to receive LMWH (pre-filled syringe containing 40 mg enoxaparin sodium in 0.4 ml) treatment at least once a day not to have any visual or auditory disorders not to have any foreknown coagulation disorders to have platelet, PTT and international normalized ratio (INR) values within the normal limits for beginning enoxaparin sodium injections not to have any hematologic disorders or any bruising or injuries at the abdominal wall to receive no injections at the abdominal site, other than the enoxaparin sodium during the research protocol to will to participate in this study Exclusion Criteria: to be pregnant have bleeding in the injection site have pain at any site of their body prior to the injection have any incision, drain, scar tissue, lipodystrophy or infection symptoms at the abdominal site which hinder the application of injection not to will to participate in this study
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
No Intervention
Group with two-minute pre-injection application of cold
Group with five-minute pre-injection application of cold
Control group
Before applying the subcutaneous injection, cold application pack was applied on the injection site for two minutes. Then, the low molecular weight heparin injection was applied to this cold-applied area in accordance with the subcutaneous heparin injection protocol. VAS assessment was made after the injection and bruise and haematoma assessments were conducted after 48 and 72 hours.
Before applying the subcutaneous injection, cold application pack was applied on the injection site for five minutes. Then, the low molecular weight heparin injection was applied to this cold-applied area in accordance with the subcutaneous heparin injection protocol. VAS assessment was made after the injection and bruise and haematoma assessments were conducted after 48 and 72 hours.
Without applying any tools or processes, the low molecular weight heparin injection was applied in accordance with the subcutaneous heparin injection protocol. VAS assessment was made after the injection and bruise and haematoma assessments were conducted after 48 and 72 hours.